Allan C. Silber - 03 Nov 2023 Form 4 Insider Report for POINT Biopharma Global Inc.

Role
Executive Chairman, Director
Signature
/s/ William L. Demers, by Power of Attorney for Allan C. Silber
Issuer symbol
N/A
Transactions as of
03 Nov 2023
Net transactions value
$0
Form type
4
Filing time
07 Nov 2023, 18:31:49 UTC
Previous filing
30 Mar 2023
Next filing
27 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PNT Common Stock Gift $0 -500,000 -93% $0.000000 38,087 03 Nov 2023 Trustee F1, F2
holding PNT Common Stock 4,268,605 03 Nov 2023 Personal Holding Company
holding PNT Common Stock 313,884 03 Nov 2023 By Spouse
holding PNT Common Stock 4,035,655 03 Nov 2023 Silber Holdings, Inc. F3
holding PNT Common Stock 71,744 03 Nov 2023 Anglian Holdings, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the gift of common stock to a charitable donor-advised fund.
F2 Held in a trust for which the Reporting Person is the trustee.
F3 Silber Holdings, Inc. is a corporation controlled by the Reporting Person.
F4 Anglian Holdings, LLC is a limited liability company solely owned by the Reporting Person.